Mark E Saad
CIK 1295913 · Chief Financial Officer · last filed 2026-06-10
Mark E Saad is a Chief Financial Officer who has filed 44 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for AXSM, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$8.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.99M
3
44
-$7.99M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AXSM | Director | 11,731 | $255.17 | $2.99M | -$8.16M | 27 | 2026-06-10 |
| Catheter Precision, Inc. (RMED) Delisted | Director | 13,750 | $0.59 | $8.2K | $0 | 5 | 2021-01-07 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | Chief Financial Officer | 138,430 | — | — | $171.8K | 12 | 2013-02-04 |
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | AXSM | Exer (M) | +1,429 | $0 | EDGAR |
| 2026-06-09 | AXSM | Grant (A) | — | $0 | EDGAR |
| 2026-01-02 | AXSM | Mixed | — | -$6.00M | EDGAR |
| 2025-09-05 | AXSM | Mixed | — | -$1.06M | EDGAR |
| 2025-06-10 | AXSM | Grant (A) | — | $0 | EDGAR |
| 2025-02-25 | AXSM | Grant (A) | — | $0 | EDGAR |
| 2024-09-11 | AXSM | Mixed | — | -$965.4K | EDGAR |
| 2024-06-11 | AXSM | Grant (A) | — | $0 | EDGAR |
| 2024-02-29 | AXSM | Grant (A) | — | $0 | EDGAR |
| 2023-06-06 | AXSM | Grant (A) | — | $0 | EDGAR |